Annual accounts receivable:
$279.30M+$400.00K(+0.14%)Summary
- As of today (May 19, 2025), UTHR annual accounts receivable is $279.30 million, with the most recent change of +$400.00 thousand (+0.14%) on December 31, 2024.
- During the last 3 years, UTHR annual accounts receivable has risen by +$80.60 million (+40.56%).
- UTHR annual accounts receivable is now -5.99% below its all-time high of $297.10 million, reached on December 31, 2017.
Performance
UTHR Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$322.00M+$42.70M(+15.29%)Summary
- As of today (May 19, 2025), UTHR quarterly accounts receivable is $322.00 million, with the most recent change of +$42.70 million (+15.29%) on March 31, 2025.
- Over the past year, UTHR quarterly accounts receivable has increased by +$14.70 million (+4.78%).
- UTHR quarterly accounts receivable is now -5.79% below its all-time high of $341.80 million, reached on September 30, 2024.
Performance
UTHR Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
UTHR Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.1% | +4.8% |
| 3 y3 years | +40.6% | +88.9% |
| 5 y5 years | +84.5% | +115.2% |
UTHR Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.6% | -5.8% | +139.4% |
| 5 y | 5-year | at high | +84.5% | -5.8% | +139.4% |
| alltime | all time | -6.0% | >+9999.0% | -5.8% | >+9999.0% |
UTHR Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $322.00M(+15.3%) |
| Dec 2024 | $279.30M(+0.1%) | $279.30M(-18.3%) |
| Sep 2024 | - | $341.80M(+17.6%) |
| Jun 2024 | - | $290.70M(-5.4%) |
| Mar 2024 | - | $307.30M(+10.2%) |
| Dec 2023 | $278.90M(+26.5%) | $278.90M(+7.8%) |
| Sep 2023 | - | $258.60M(-5.2%) |
| Jun 2023 | - | $272.70M(+102.8%) |
| Mar 2023 | - | $134.50M(-39.0%) |
| Dec 2022 | $220.40M(+10.9%) | $220.40M(-4.9%) |
| Sep 2022 | - | $231.70M(+33.6%) |
| Jun 2022 | - | $173.40M(+1.7%) |
| Mar 2022 | - | $170.50M(-14.2%) |
| Dec 2021 | $198.70M(+26.2%) | $198.70M(-6.6%) |
| Sep 2021 | - | $212.80M(+22.7%) |
| Jun 2021 | - | $173.40M(+22.9%) |
| Mar 2021 | - | $141.10M(-10.4%) |
| Dec 2020 | $157.40M(+4.0%) | $157.40M(+3.3%) |
| Sep 2020 | - | $152.30M(-11.5%) |
| Jun 2020 | - | $172.00M(+15.0%) |
| Mar 2020 | - | $149.60M(-1.2%) |
| Dec 2019 | $151.40M(-13.8%) | $151.40M(-17.5%) |
| Sep 2019 | - | $183.60M(+1.4%) |
| Jun 2019 | - | $181.00M(+13.3%) |
| Mar 2019 | - | $159.80M(-9.0%) |
| Dec 2018 | $175.70M(-40.9%) | $175.70M(-18.4%) |
| Sep 2018 | - | $215.20M(-14.4%) |
| Jun 2018 | - | $251.30M(+19.0%) |
| Mar 2018 | - | $211.10M(-28.9%) |
| Dec 2017 | $297.10M(+38.5%) | $297.10M(+18.0%) |
| Sep 2017 | - | $251.80M(-8.1%) |
| Jun 2017 | - | $273.90M(+45.7%) |
| Mar 2017 | - | $188.00M(-12.4%) |
| Dec 2016 | $214.50M(+11.3%) | $214.50M(-4.5%) |
| Sep 2016 | - | $224.60M(-5.7%) |
| Jun 2016 | - | $238.10M(+22.2%) |
| Mar 2016 | - | $194.80M(+1.0%) |
| Dec 2015 | $192.80M(+18.8%) | $192.80M(+7.3%) |
| Sep 2015 | - | $179.64M(+6.2%) |
| Jun 2015 | - | $169.21M(+8.4%) |
| Mar 2015 | - | $156.15M(-3.8%) |
| Dec 2014 | $162.29M(+28.5%) | $162.29M(+16.0%) |
| Sep 2014 | - | $139.90M(-34.3%) |
| Jun 2014 | - | $212.90M(+61.6%) |
| Mar 2014 | - | $131.77M(+4.3%) |
| Dec 2013 | $126.30M | $126.30M(-3.3%) |
| Sep 2013 | - | $130.64M(-0.7%) |
| Jun 2013 | - | $131.56M(+29.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $101.35M(-13.1%) |
| Dec 2012 | $116.63M(+31.5%) | $116.63M(+7.0%) |
| Sep 2012 | - | $108.95M(+10.5%) |
| Jun 2012 | - | $98.58M(+10.6%) |
| Mar 2012 | - | $89.15M(+0.5%) |
| Dec 2011 | $88.68M(+20.3%) | $88.68M(+1.5%) |
| Sep 2011 | - | $87.39M(+5.9%) |
| Jun 2011 | - | $82.53M(+26.2%) |
| Mar 2011 | - | $65.42M(-11.2%) |
| Dec 2010 | $73.71M(+45.6%) | $73.71M(-2.5%) |
| Sep 2010 | - | $75.57M(-9.5%) |
| Jun 2010 | - | $83.51M(+39.6%) |
| Mar 2010 | - | $59.81M(+18.2%) |
| Dec 2009 | $50.63M(+78.8%) | $50.63M(+10.9%) |
| Sep 2009 | - | $45.65M(+32.8%) |
| Jun 2009 | - | $34.37M(-30.4%) |
| Mar 2009 | - | $49.41M(+74.5%) |
| Dec 2008 | $28.31M(+10.4%) | $28.31M(-14.4%) |
| Sep 2008 | - | $33.09M(+9.7%) |
| Jun 2008 | - | $30.18M(+15.6%) |
| Mar 2008 | - | $26.11M(+1.8%) |
| Dec 2007 | $25.65M(+14.3%) | $25.65M(+1.6%) |
| Sep 2007 | - | $25.25M(+8.7%) |
| Jun 2007 | - | $23.23M(+22.2%) |
| Mar 2007 | - | $19.01M(-15.3%) |
| Dec 2006 | $22.45M(+61.8%) | $22.45M(+26.2%) |
| Sep 2006 | - | $17.80M(-0.8%) |
| Jun 2006 | - | $17.95M(+22.9%) |
| Mar 2006 | - | $14.60M(+5.2%) |
| Dec 2005 | $13.87M(+0.9%) | $13.87M(-13.1%) |
| Sep 2005 | - | $15.97M(+3.4%) |
| Jun 2005 | - | $15.45M(+12.6%) |
| Mar 2005 | - | $13.72M(-0.2%) |
| Dec 2004 | $13.74M(+35.4%) | $13.74M(+27.3%) |
| Sep 2004 | - | $10.79M(+11.2%) |
| Jun 2004 | - | $9.70M(+27.1%) |
| Mar 2004 | - | $7.63M(-24.8%) |
| Dec 2003 | $10.15M(+5.2%) | $10.15M(+15.4%) |
| Sep 2003 | - | $8.80M(-13.0%) |
| Jun 2003 | - | $10.11M(+4.2%) |
| Mar 2003 | - | $9.71M(+0.6%) |
| Dec 2002 | $9.65M(+564.5%) | $9.65M(-17.4%) |
| Sep 2002 | - | $11.68M(+10.3%) |
| Jun 2002 | - | $10.59M(+498.5%) |
| Mar 2002 | - | $1.77M(+21.8%) |
| Dec 2001 | $1.45M | $1.45M(-4.0%) |
| Sep 2001 | - | $1.51M(-52.0%) |
| Jun 2001 | - | $3.15M(+21.2%) |
| Mar 2001 | - | $2.60M |
FAQ
- What is United Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for United Therapeutics?
- What is United Therapeutics annual accounts receivable year-on-year change?
- What is United Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for United Therapeutics?
- What is United Therapeutics quarterly accounts receivable year-on-year change?
What is United Therapeutics annual accounts receivable?
The current annual accounts receivable of UTHR is $279.30M
What is the all time high annual accounts receivable for United Therapeutics?
United Therapeutics all-time high annual accounts receivable is $297.10M
What is United Therapeutics annual accounts receivable year-on-year change?
Over the past year, UTHR annual accounts receivable has changed by +$400.00K (+0.14%)
What is United Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of UTHR is $322.00M
What is the all time high quarterly accounts receivable for United Therapeutics?
United Therapeutics all-time high quarterly accounts receivable is $341.80M
What is United Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, UTHR quarterly accounts receivable has changed by +$14.70M (+4.78%)